Skip to main content
Premium Trial:

Request an Annual Quote

Intermountain Precision Genomics ICG100 Panel Expansion

Intermountain Precision Genomics announced today the expansion of the ICG100 panel, a test which identifies mutations, and then targets mutations with a personalized therapy. The panel expansion includes 162 genes often associated in cancer pathways. The panel is approved for late stage cancer patients who have failed to receive results from a traditional treatment method.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.